Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
1.5K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative.

Acta diabetologica·2026
Same author

Association between electronic cigarette use and prediabetes, diabetes, and insulin resistance: a systematic review and meta-analysis.

Internal and emergency medicine·2026
Same author

Causes and consequences of discontinuation of GLP1RAs or tirzepatide.

Nature reviews. Endocrinology·2026
Same author

Lung cancer in primary care: Development & validation of a prediction algorithm.

Cancer epidemiology·2026
Same author

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

The lancet. Diabetes & endocrinology·2026
Same author

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Cardiovascular diabetology·2026

Related Experiment Video

Updated: Apr 27, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach.

Antonio Ceriello1, Marco Gallo2, Riccardo Candido3

  • 1Department of Endocrinology, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer, Barcelona, Spain ; Centro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metabolicas Asociadas, Barcelona, Spain.

Pharmacogenomics and Personalized Medicine
|June 28, 2014
PubMed
Summary
This summary is machine-generated.

A new personalized algorithm helps manage type 2 diabetes by tailoring treatment to individual patient phenotypes, including hyperglycemia patterns and risk factors. This approach aims to improve metabolic control and reduce diabetes complications.

Keywords:
Italian Association of Medical DiabetologistsItalian algorithmpersonalized treatmenttreatment guidelinestype 2 diabetes

More Related Videos

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

3.8K

Related Experiment Videos

Last Updated: Apr 27, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

3.8K

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Clinical Medicine

Background:

  • Type 2 diabetes is a progressive, multifactorial disease with diverse clinical presentations.
  • Varied hyperglycemia phenotypes (fasting/preprandial, postprandial) complicate treatment selection, leading to delayed initiation or optimization.
  • Despite existing guidelines, many patients lack optimal metabolic control, increasing risks of long-term diabetes complications.

Purpose of the Study:

  • To introduce an innovative, personalized treatment algorithm for type 2 diabetes developed by the Italian Association of Medical Diabetologists.
  • To provide physicians with an accessible tool for tailoring and optimizing type 2 diabetes management based on individual patient characteristics.
  • To address clinical inertia in type 2 diabetes treatment by facilitating timely and personalized therapeutic decisions.

Main Methods:

  • Development of six distinct online algorithms based on patient features: glycated hemoglobin (HbA1c), body mass index, occupational hypoglycemia risk, chronic renal failure, and frail elderly status.
  • Patient phenotyping based on self-monitoring of blood glucose to identify fasting/preprandial or postprandial hyperglycemia.
  • Stepwise treatment selection within each algorithm, considering metformin intolerance and personalizing glycemic targets (HbA1c, fasting/preprandial, and postprandial glycemia).

Main Results:

  • The algorithm offers a personalized, stepwise approach to type 2 diabetes treatment selection and optimization.
  • It accounts for specific patient phenotypes, including different hyperglycemia patterns and comorbidities.
  • The tool is designed to be accessible and easy to use, aiding physicians in clinical decision-making.

Conclusions:

  • The personalized algorithm represents an innovative approach to managing type 2 diabetes.
  • It empowers physicians to tailor treatment effectively, potentially improving patient outcomes and reducing diabetes-related complications.
  • The algorithm aims to overcome barriers to optimal diabetes care, such as clinical inertia and treatment complexity.